Castro-Aldrete, Laura https://orcid.org/0000-0002-5530-3653
Einsiedler, Melanie
Novakova Martinkova, Julie https://orcid.org/0000-0002-7726-9847
Depypere, Herman
Alvin Ang, Ting Fang https://orcid.org/0000-0003-4687-2552
Mielke, Michelle M. https://orcid.org/0000-0001-7177-1185
Sindi, Shireen
Eyre, Harris A.
Au, Rhoda https://orcid.org/0000-0001-7742-4491
Schumacher Dimech, Anne Marie https://orcid.org/0000-0002-8016-5811
Dé, Anna
Szoeke, Cassandra
Tartaglia, Maria Carmela https://orcid.org/0000-0002-5944-8497
Santuccione Chadha, Antonella
Article History
Accepted: 17 February 2025
First Online: 14 April 2025
Competing interests
: L.C.-A. was the scientific project manager of the Womens Brain Foundation (WBF). R.A. declares that she has acted as a scientific adviser to Novo Nordisk and Signant Health and as a consultant for Davos Alzheimer’s Collaborative. M.M.M. declares that she has served on scientific advisory boards and/or has consulted for Biogen, Eisai, LabCorp, Lilly, Merck, Novo Nordisk, Roche, Siemens Healthineers and Sunbird Bio. M.C.T. declares that she has served on scientific advisory boards and/or has consulted for Eisai, Lilly, Novo Nordisk and Roche. H.A.E. declares that he is an employee of the Baker Institute for Public Policy at Rice University, Houston, TX, USA, and that he has received fees for consulting from Altoida, Kooth and Meadows Mental Health Policy Institute and Novo Nordisk, as well as fees for speaking from Lundbeck, Novo Nordisk and Roche. A.S.C. declares that she is the co-founder and pro bono chief executive officer of the WBF. M.E., H.D., T.F.A.A., S.S., R.A., A.M.S.D., A.D., C.S. and J.N.M. declare no competing interests.